Skip to main content


Firm News

Mayer Brown JSM advises Fosun Pharmaceutical on private placement in Nature’s Sunshine Products

7 July 2014
Mayer Brown has advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma") on its subscription of shares in Nature's Sunshine Products, Inc. ("NSP"), a NASDAQ-listed US manufacturer of natural health supplements, for a consideration of approximately US$46.3 million pursuant to a private placement

The firm is also advising Fosun Industrial (HK) Co., Ltd. ("Fosun Industrial"), a wholly-owned subsidiary of Fosun Pharma, on the establishment of a China joint venture with NSP, to market and distribute Nature's Sunshine and Synergy products in China. The strategic partnership highlights Fosun Pharma's commitment to investing in companies that deliver value in the rapidly growing business segments in China and internationally. The joint venture is the first-of-its-kind direct selling company between a Chinese and a US company to operate in China, giving the new venture a competitive edge in the marketplace. The team consists partners Reb Wheeler and John Berkery (New York), and they were assisted by associate Mandee Lee (New York).

Media Contact

  • John D. Tuerck
    Director of Public Relations
    T +1 312 701 8280

Related Information

  • Related People
    Reb D. Wheeler
    T +1 212 506 2414
    John P. Berkery
    T +1 212 506 2552
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.